Idorsia
Christelle Boniface has extensive experience in the pharmaceutical industry, with a focus on regulatory affairs and project management. Christelle began their career at ICTA as a Clinical Research Associate, before joining TxCell as a Quality Assurance Manager and later becoming a Clinical Project Manager. In 2012, they took on the role of Director of Regulatory Affairs at TxCell, where they worked until 2017. Currently, Christelle serves as the Associate Director and Global Drug Regulatory Affairs Project Leader at Idorsia Pharmaceuticals Ltd.
Christelle Boniface has a DESS de Biotechnologie degree from Faculté des Sciences et Techniques de Limoges, with a field of study in Génie cellulaire et moléculaire. Christelle also has an IUP Bioingénierie degree from Université Paul Sabatier Toulouse III, with a field of study in Technologies moléculaires en biologie et santé.
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.